Self-myofascial Release Improves Function and Is Safe In Hemophilic Ankle Arthropathy .
Safety and efficacy of myofascial release therapy in the treatment of patients with hemophilic ankle arthropathy. Single-blind randomized clinical trial.
Physiother Theory Pract . 2025 Feb;41(2):289-298.Fifty-eight patients with hemophilic ankle arthropathy were randomized to self-myofascial release with a foam roller (n=29) or no intervention (n=29). The primary outcome was safety (frequency of ankle hemarthrosis via weekly follow-up). Secondary outcomes were pain (VAS), ankle ROM (goniometer), functional capacity (2-Minute Walk Test), and muscle strength (hand-held dynamometer). Outcomes were measured at baseline, 8 weeks (end of intervention), and ~10 weeks (follow-up). Overall, the results showed zero hemarthroses during the intervention in the myofascial-release group and significant time*group effects favoring the intervention for dorsiflexion, functional capacity, and gastrocnemius strength. In short, a brief daily foam-rolling program appeared safe and produced clinically relevant gains in ankle dorsiflexion, walking capacity, and calf strength.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics